Search Articles
clear search termsPractitioner Missteps in Resolving Metabolic Dysfunction
Although you may already be a savvy practitioner, we are certain you will learn something new in this video about ‘Practitioner Missteps in Resolving Metabolic Dysfunction‘. You’ll walk away with inspiration and ideas you can use in your practice right away.
Here are some of the things we’ll be unveiling:
- Waiting for blood glucose to be notably high? You have likely missed these earlier three stages of metabolic dysfunction.
- Yes! Focus on diet, stress and sleep, but don’t forget THIS too when addressing stubborn Insulin Resistance and T2DM.
- Crossroads of metabolic and gastrointestinal distress: the pancreatic dysfunction that is often unrecognized.
- This hormone (not Insulin) directly affects your patients’ fasting glucose and HbA1c – regardless of diet! Are you assessing and optimizing it?
- Considering GLP-1’s role in your patients metabolic dysfunction? Look at the microbiome for important devil-in-the-detail!
- Meet Jane. In exactly 10 years, she’s going to get a T2DM diagnosis. But the evidence is lurking in her labs Right Now. Do you know what to look for?
- These 4 high-value supplements have a powerful place in your metabolic health toolbox. Are you using them?
Thank you for joining in the inspiration and learning!
P.S. If you are passionate about transforming healthcare through the power of functional medicine, we encourage you to learn more about SAFM’s practitioner training programs. Enrollment for our next cohort is now open!
To receive weekly clinical tips for practitioners – like this one – right to your inbox, register here.
Follow us on Facebook and/or on Youtube to gain more rich clinical content.
80 Questions for “Practitioner Missteps in Resolving Metabolic Dysfunction”
-
78
-
78.1
Indeed, exocrine pancreatic insufficiency (EPI) can increase the risk of developing diabetes, or vice versa; diabetes can lead to EPI (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708123/). Thus, it would make sense to examine the situation by checking fasting insulin and/or c-peptide.
-
-
77
Sarah B Townley says:
Thank you for this awesome video! The one thing I loved learning was that hypothyroidism somehow promotes fatty liver disease that can develop into type 2 diabetes. I would love more information on that. And thank you for the access to the reversing metabolic disease workshop.
-
77.1
You are most welcome! We are truly delighted to support your learning and passion for the functional medicine approach. Here are a couple of publications that may find interesting regarding this interconnectedness:
https://onlinelibrary.wiley.com/doi/full/10.1111/liv.15723
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926038/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158236/
-
-
76
Lisa Lamanna says:
I loved when Tracy spoke about the pancreas. Such an important function. And my mind was blown away with the Ah Ha moment that 13 years leading up to the DX. So much can be done in a preventative sense.
-
75
Jacqueline Folch says:
What caught my attention is to know that at early stages of metabolic dysfunction hypoglycemia almost always presents before hyperglycemia and that occurs even 13 years before !
-
74
Roberta McMaster says:
A great pearl I learned was the Interconnectedness of how anemia influences HgA1C. An aha moment for sure!
Thank you so much! -
73
Echo Macdonald says:
The inspiration to include HbA1c and fasting insulin in all testing for new patients, to catch the cases of insulin resistance early on before damage has progressed to disease.
-
72
Linda Pearson says:
You are talking about how things were for me 25 years ago. I need the follow on for those who have progressed with metabolic disease beyond this point.
-
71
Marianne Connelly says:
Very informative! I found it interesting that Fasting insulin or fasting C-peptide can be elevated 13 years before diabetes diagnosis and will use this info going forward when assessing my patients.
-
70
Linda Kiehnau says:
It was new to me that inositol can help reverse Insulin Resistance. Thanks!
-
69
Lori A Lamb says:
It’s always good to hear again how beneficial our services are in being able to head off disease dynamics like Insulin Resistance by keeping an eye on Fasting Glucose and C-Peptide and making sure that clients are informed on how and why to request that test.
-
68
Pam Barefoot says:
I did not realize the root cause or inter connectedness between subclinical hypothyroidism and NAFLD. I also had never heard of d-leonine and didn’t realize that berberine was as effective as metformin for T2DM.
-
67
Effie Saly says:
Thank you for reminding us about eating hygiene
very powerful presentation. Thank you -
66
Brandi Clokey says:
Very informative talk. I did not know about the link between akkermansia, short chain fatty acids and GLP-1 one levels. Information about inositol and berberine on insulin resistance was new to me, a lot to start researching for more information.
Thank you!
-
65
Shilpy setya says:
I loved learning about the impact of scfa and the importance of feeding bacteria that produce SCFAs
-
64
Kristen Perry says:
C-Peptide as predictive marker.
-
63
JENNIFER NATHANSON says:
Reminded about motility impacting incretin release and first pass insulin response.
-
62
THERESA WARNAGIRIS, D.C. says:
Never knew A1C could be unreliable due to anemia
-
61
Wendy Tobin says:
One of my earlier careers was 20+years in dentistry so I found the link of Periodontal Disease to Diabetes so interesting along with the enhanced permeability in the gingival tissue leading to Hypertension! Funny while in dentistry I never heard the term oral micro biome! We treated the mouth, right! Makes so much sense that what happens in the mouth doesn’t stay in the mouth! Wow! I’m going to keep my teeth cleaner! Oh! I’m not a practitioner, my business is Milwaukee Pet Sitters,Inc, but a very close friend has inspired me over the years to learn about functional medicine and so I’m learning so much while she is on her journey through your program. Thank you Tracy! Thank you Deb!
Ask a Question
Practitioner clarification questions are welcome! Please do not post personal case inquiries.
© 2017-, The School of Applied Functional Medicine | Company Values | Terms of Use | Legal/Privacy | Contact
web development by: Gordon Multimedia
Would a 51 yo overweight Hispanic male with a family hx of DM recently diagnosed with what appears to be “idiopathic” exocrine pancreatic insufficiency be at a greater risk for advancing to DM since the pancreas is starting to show dysfunction? A16 is 5%, but isn’t looking at fasting insulin and c-peptide warranted in this case?